Demsky was a previous Health Lab contributor and member of the public relations team.
Health Lab
A genetic counselor discusses decision-making for people who carry BRCA1 and BRCA2 mutations
Health Lab
A genetic counselor discusses how genetic testing can help guide treatment decisions and well as inform preventive measures.
Health Lab
Structural biology techniques helped researchers target the nuclear receptor-binding SET domain family, whose malfunction is associated with several types of cancer.
Health Lab
Single-cell RNA sequencing study offers new insights that could help researchers make chemotherapy more effective in the future.
Health Lab
A genetic counselor discusses the impact of these mutations and the importance of collecting family histories.
Health Lab
In mouse models of DIPG, simultaneously attacking two metabolic pathways led to significant improvements in survival.
Health Lab
Anti-androgen therapy showed positive results in cell lines and animal models.
Health Lab
Cancer treatment research for glioblastoma enters new phase with FDA-approved drug trial that aims to improve the effect of radiation therapy on this aggressive brain cancer.
Health Lab
The multi-institution phase 1b/2a clinical trial found good tolerability and encouraging efficacy data for the pan-BET bromodomain inhibitor in combination with enzalutamide.
Health Lab
While heat shock protein 90 inhibitors have shown limited benefit in directly treating cancer, low doses may improve the efficacy of radiotherapy, a new study finds.
Health Lab
Multi-institution analysis identifies a new chromosomal abnormality linked to enzalutamide resistance.
Health Lab
A Rogel Cancer Center lung doctor discusses recommendations that annual screenings start at age 50 for current and former smokers with 20 “pack years”.
Health Lab
The terms can be confusing — advanced cancer, metastatic cancer, late-stage cancer, stage 4 cancer, secondary cancer, recurrent cancer. Here’s what patients need to know.
Health Lab
Rather than attacking cancer cells directly, new cell-model research probes weaknesses in pancreatic cancer’s interactions with other cells to obtain nutrients needed for tumor growth.
Health Lab
New ovarian cancer research shows microRNA biomarker miR-181a could hold the key to earlier detection and treatment of the disease.